Colloquium

Dr. Heiko Runz
Head of Human Genetics at Biogen, Cambridge, Massachusetts, USA

How large-scale human biobanks are transforming drug discovery and development

Prof. Guillaume Canaud
Hôpital Necker-Enfants Malades, Université de Paris

Targeted therapy in patients with PIK3CA-related overgrowth spectrum: from discovery to clinical approval

Prof. Dr. Hilmar Bading
IZN, Heidelberg

NMDAR/TRPM4 interface inhibitors: new pharmacological principle for treatment of human neurodegenerative diseases

Prof. Dr. rer. nat. Lisa Wiesmüller
Universitätsfrauenklinik, Ulm

PALB2 and ABRAXAS1 orchestrate BRCA1 activities to counter genome destabilizing repair pathways – lessons from familial breast cancer cases

Prof. Dr. Martin Kircher
Institut für Humangenetik, UKSH Lübeck

CADD and CADD-SV - scoring deleteriousness of all genomic variants

Prof. Dr. Ralf Müller-Terpitz
Fakultät für Rechtswissenschaft und Volkswirtschaftslehre, Mannheim

The Protection of Genetic Information under Data Protection Law – Possibilities and Boundaries